These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression. Wei J; Qi X; Zhan Q; Zhou D; Yan Q; Wang Y; Mo L; Wan Y; Xie D; Xie J; Yang S Biomed Pharmacother; 2015 Apr; 71():112-8. PubMed ID: 25960225 [TBL] [Abstract][Full Text] [Related]
3. LRIG1 enhances the radiosensitivity of radioresistant human glioblastoma U251 cells via attenuation of the EGFR/Akt signaling pathway. Yang JA; Liu BH; Shao LM; Guo ZT; Yang Q; Wu LQ; Ji BW; Zhu XN; Zhang SQ; Li CJ; Chen QX Int J Clin Exp Pathol; 2015; 8(4):3580-90. PubMed ID: 26097540 [TBL] [Abstract][Full Text] [Related]
4. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway. Li Y; Ma X; Wang Y; Li G Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of LRIG1 expression by RNA interference promotes the aggressive properties of glioma cells via EGFR/Akt/c-Myc activation. Xie R; Yang H; Xiao Q; Mao F; Zhang S; Ye F; Wan F; Wang B; Lei T; Guo D Oncol Rep; 2013 Jan; 29(1):177-84. PubMed ID: 23124613 [TBL] [Abstract][Full Text] [Related]
6. MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein. Yao Y; Ma J; Xue Y; Wang P; Li Z; Li Z; Hu Y; Shang X; Liu Y Mol Oncol; 2015 Mar; 9(3):640-56. PubMed ID: 25487955 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1. Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337 [TBL] [Abstract][Full Text] [Related]
8. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas. Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108 [TBL] [Abstract][Full Text] [Related]
9. miR-221/222 confers radioresistance in glioblastoma cells through activating Akt independent of PTEN status. Li W; Guo F; Wang P; Hong S; Zhang C Curr Mol Med; 2014 Jan; 14(1):185-95. PubMed ID: 24295494 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-590-3p enhances the radioresistance in glioblastoma cells by targeting LRIG1. Chen L; Wang W; Zhu S; Jin X; Wang J; Zhu J; Zhou Y Exp Ther Med; 2017 Aug; 14(2):1818-1824. PubMed ID: 28810655 [TBL] [Abstract][Full Text] [Related]
11. miR-340 suppresses glioblastoma multiforme. Huang D; Qiu S; Ge R; He L; Li M; Li Y; Peng Y Oncotarget; 2015 Apr; 6(11):9257-70. PubMed ID: 25831237 [TBL] [Abstract][Full Text] [Related]
12. LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR/topoisomerase-2/Bcl-2. Qi XC; Xie DJ; Yan QF; Wang YR; Zhu YX; Qian C; Yang SX Biochem Biophys Res Commun; 2013 Aug; 437(4):565-72. PubMed ID: 23850692 [TBL] [Abstract][Full Text] [Related]
13. Soluble LRIG2 ectodomain is released from glioblastoma cells and promotes the proliferation and inhibits the apoptosis of glioblastoma cells in vitro and in vivo in a similar manner to the full-length LRIG2. Xiao Q; Tan Y; Guo Y; Yang H; Mao F; Xie R; Wang B; Lei T; Guo D PLoS One; 2014; 9(10):e111419. PubMed ID: 25353163 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-96 promotes radioresistance in glioblastoma cells via targeting PDCD4. Guo P; Yu Y; Tian Z; Lin Y; Qiu Y; Yao W; Zhang L Int J Oncol; 2018 Oct; 53(4):1591-1600. PubMed ID: 30066909 [TBL] [Abstract][Full Text] [Related]
15. miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells. Li XT; Wang HZ; Wu ZW; Yang TQ; Zhao ZH; Chen GL; Xie XS; Li B; Wei YX; Huang YL; Zhou YX; Du ZW Cell Mol Neurobiol; 2015 Jul; 35(5):679-87. PubMed ID: 25662849 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas. Wang B; Sun F; Dong N; Sun Z; Diao Y; Zheng C; Sun J; Yang Y; Jiang D Diagn Pathol; 2014 Nov; 9():211. PubMed ID: 25394492 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-153-3p enhances cell radiosensitivity by targeting BCL2 in human glioma. Sun D; Mu Y; Piao H Biol Res; 2018 Dec; 51(1):56. PubMed ID: 30537994 [TBL] [Abstract][Full Text] [Related]
18. Cathepsin B contributes to radioresistance by enhancing homologous recombination in glioblastoma. Zhang X; Wang X; Xu S; Li X; Ma X Biomed Pharmacother; 2018 Nov; 107():390-396. PubMed ID: 30099343 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1. Jiang C; Shen F; Du J; Hu Z; Li X; Su J; Wang X; Huang X Oncotarget; 2016 Aug; 7(35):56200-56208. PubMed ID: 27621042 [TBL] [Abstract][Full Text] [Related]
20. Over-expression of LRIG1 suppresses biological function of pituitary adenoma via attenuation of PI3K/AKT and Ras/Raf/ERK pathways in vivo and in vitro. Cheng SQ; Fan HY; Xu X; Gao WW; Lv SG; Ye MH; Wu MJ; Shen XL; Cheng ZJ; Zhu XG; Zhang Y J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):558-563. PubMed ID: 27465333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]